邢文阁, 郭玉琴, 李保国, 倪虹, 郭秀英, 于海鹏, 郭志. 椎体成形术治疗乳腺癌椎体转移33例疗效分析[J]. 中国肿瘤临床, 2008, 35(1): 1-4.
引用本文: 邢文阁, 郭玉琴, 李保国, 倪虹, 郭秀英, 于海鹏, 郭志. 椎体成形术治疗乳腺癌椎体转移33例疗效分析[J]. 中国肿瘤临床, 2008, 35(1): 1-4.
XING Wenge, GUO Yuqin, LI Baoguo, NI Hong, GUO Xiuying, YU Haipeng, GUO Zhi. Percutaneous Vertebroplasty for Bone Metastasis of Breast Carcinoma: A Report on 33 Cases[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2008, 35(1): 1-4.
Citation: XING Wenge, GUO Yuqin, LI Baoguo, NI Hong, GUO Xiuying, YU Haipeng, GUO Zhi. Percutaneous Vertebroplasty for Bone Metastasis of Breast Carcinoma: A Report on 33 Cases[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2008, 35(1): 1-4.

椎体成形术治疗乳腺癌椎体转移33例疗效分析

Percutaneous Vertebroplasty for Bone Metastasis of Breast Carcinoma: A Report on 33 Cases

  • 摘要: 目的: 对乳腺癌椎体转移放化疗及药物治疗无明显疗效患者行经皮穿刺椎体成形术(Percutaneous Vert-erbreplasty,PVP)治疗并进行疗效分析。 方法: 以PVP治疗乳腺癌合并脊柱骨转移接受放疗、化疗及药物治疗无明显疗效患者33例,术后进行随访,采用数字分级法(NRS)对治疗前后疼痛评价;应用EORTCQLQ—C30行问卷调查并分析治疗前后生活质量变化;观察治疗并发症。 结果: PVP技术成功率100%,CT示所有椎体转移灶均填充良好;术前NRS评分为6.69±1.67分,术后6小时为3.09±1.84分,疼痛明显缓解(t=10.886,P=0.000);术前EORTCQLQ—C30评分为60.60±3.57分,术后6小时为34.61±4.31分,生活质量明显提高(t=43.924,P=0.000);无引起临床症状的并发症发生。 结论: PVP方法治疗乳腺癌椎体转移安全有效,生活质量提高显著。

     

    Abstract: Objective: To investigate the effect of percutaneous vertebroplasty(PVP) used to treat bone metastasis of breast carcinoma. Methods: Data from 32 female patients with breast carcinoma and vertebral metastasis who received PVP were analyzed. Before PVP treatment, these patients were given chemotherapy or radiotherapy, and no obvious effect on the bone metastases was observed. Changes in pain intensity were assessed by NRS. Improvements in quality of life were evaluated by questionnaire EORTC QLQ-C30. The side effects were also observed. Results: The success rate of PVP was 100%. CT demonstrated that all of the defects from the vertebral metastases were fully filled by Polymethylmethacrylate(PMMA). The NRS was 6.69± 1.67 before PVP and was 3.09±1.84 at the 6th hour after the procedure (t=10.886, P=0.000). The score on the EORTC QLQ-C30 questionnaire was 60.60±3.57 before PVP and 34.61±4.31 at the 6th hour after PVP. The above data indicate that PVP decreased the patients' pain and improved their quality of life (t=43.924, P=0.000). No severe clinical complications were observed. Conclusion: PVP is a safe and effective treatment for breast carcinoma patients with vertebral metastasis.

     

/

返回文章
返回